APO RESEARCH · REPORT
Glycated Albumin
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Product & engineering
Understand the product.
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
Selected research
Industry Research
Glycated Albumin Industry Research Report 2026
Market perspective
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
Read the full market overview
The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.
Report Scope
This report quantifies the global Glycated Albumin market in terms of revenue (US$ million) and, where applicable, sales volume (Kits), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kits) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glycated Albumin Market by Company
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
Glycated Albumin Segment by Type
Glycated Albumin (Human)
Glycated Albumin (Animal)
Glycated Albumin Segment by Application
Hospitals and Clinics
Laboratories
Glycated Albumin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycated Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycated Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycated Albumin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glycated Albumin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glycated Albumin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glycated Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glycated Albumin (Human)
- Glycated Albumin (Animal)
Applications
- Hospitals and Clinics
- Laboratories
Companies covered
- Asahi Kasei Pharma
- DIAZYME
- Abnova
- LifeSpan
- Exocell
- BSBE
- Medicalsystem
- Maccura
- Leadman
- Simes Sikma
- NINGBO PUREBIO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glycated Albumin Market Size (2021-2032)
- 2.2.2 Global Glycated Albumin Sales (2021-2032)
- 2.2.3 Global Glycated Albumin Market Average Price (2021-2032)
- 2.3 Glycated Albumin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glycated Albumin (Human)
- 2.3.3 Glycated Albumin (Animal)
- 2.4 Glycated Albumin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals and Clinics
- 2.4.3 Laboratories
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glycated Albumin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glycated Albumin Sales (Kits) of Manufacturers (2021-2026)
- 3.3 Global Glycated Albumin Revenue of Manufacturers (2021-2026)
- 3.4 Global Glycated Albumin Average Price by Manufacturers (2021-2026)
- 3.5 Global Glycated Albumin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glycated Albumin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glycated Albumin, Product Type & Application
- 3.8 Global Manufacturers of Glycated Albumin, Established Date
- 3.9 Global Glycated Albumin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Asahi Kasei Pharma
- 4.1.1 Asahi Kasei Pharma Company Information
- 4.1.2 Asahi Kasei Pharma Business Overview
- 4.1.3 Asahi Kasei Pharma Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Asahi Kasei Pharma Glycated Albumin Product Portfolio
- 4.1.5 Asahi Kasei Pharma Recent Developments
- 4.2 DIAZYME
- 4.2.1 DIAZYME Company Information
- 4.2.2 DIAZYME Business Overview
- 4.2.3 DIAZYME Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 DIAZYME Glycated Albumin Product Portfolio
- 4.2.5 DIAZYME Recent Developments
- 4.3 Abnova
- 4.3.1 Abnova Company Information
- 4.3.2 Abnova Business Overview
- 4.3.3 Abnova Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abnova Glycated Albumin Product Portfolio
- 4.3.5 Abnova Recent Developments
- 4.4 LifeSpan
- 4.4.1 LifeSpan Company Information
- 4.4.2 LifeSpan Business Overview
- 4.4.3 LifeSpan Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 LifeSpan Glycated Albumin Product Portfolio
- 4.4.5 LifeSpan Recent Developments
- 4.5 Exocell
- 4.5.1 Exocell Company Information
- 4.5.2 Exocell Business Overview
- 4.5.3 Exocell Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Exocell Glycated Albumin Product Portfolio
- 4.5.5 Exocell Recent Developments
- 4.6 BSBE
- 4.6.1 BSBE Company Information
- 4.6.2 BSBE Business Overview
- 4.6.3 BSBE Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BSBE Glycated Albumin Product Portfolio
- 4.6.5 BSBE Recent Developments
- 4.7 Medicalsystem
- 4.7.1 Medicalsystem Company Information
- 4.7.2 Medicalsystem Business Overview
- 4.7.3 Medicalsystem Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Medicalsystem Glycated Albumin Product Portfolio
- 4.7.5 Medicalsystem Recent Developments
- 4.8 Maccura
- 4.8.1 Maccura Company Information
- 4.8.2 Maccura Business Overview
- 4.8.3 Maccura Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Maccura Glycated Albumin Product Portfolio
- 4.8.5 Maccura Recent Developments
- 4.9 Leadman
- 4.9.1 Leadman Company Information
- 4.9.2 Leadman Business Overview
- 4.9.3 Leadman Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Leadman Glycated Albumin Product Portfolio
- 4.9.5 Leadman Recent Developments
- 4.10 Simes Sikma
- 4.10.1 Simes Sikma Company Information
- 4.10.2 Simes Sikma Business Overview
- 4.10.3 Simes Sikma Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Simes Sikma Glycated Albumin Product Portfolio
- 4.10.5 Simes Sikma Recent Developments
- 4.11 NINGBO PUREBIO
- 4.11.1 NINGBO PUREBIO Company Information
- 4.11.2 NINGBO PUREBIO Business Overview
- 4.11.3 NINGBO PUREBIO Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 NINGBO PUREBIO Glycated Albumin Product Portfolio
- 4.11.5 NINGBO PUREBIO Recent Developments
5 Global Glycated Albumin Market Scenario by Region
- 5.1 Global Glycated Albumin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glycated Albumin Sales by Region: 2021-2032
- 5.2.1 Global Glycated Albumin Sales by Region: 2021-2026
- 5.2.2 Global Glycated Albumin Sales by Region: 2027-2032
- 5.3 Global Glycated Albumin Revenue by Region: 2021-2032
- 5.3.1 Global Glycated Albumin Revenue by Region: 2021-2026
- 5.3.2 Global Glycated Albumin Revenue by Region: 2027-2032
- 5.4 North America Glycated Albumin Market Facts & Figures by Country
- 5.4.1 North America Glycated Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glycated Albumin Sales by Country (2021-2032)
- 5.4.3 North America Glycated Albumin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glycated Albumin Market Facts & Figures by Country
- 5.5.1 Europe Glycated Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glycated Albumin Sales by Country (2021-2032)
- 5.5.3 Europe Glycated Albumin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glycated Albumin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glycated Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glycated Albumin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glycated Albumin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glycated Albumin Market Facts & Figures by Country
- 5.7.1 South America Glycated Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glycated Albumin Sales by Country (2021-2032)
- 5.7.3 South America Glycated Albumin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glycated Albumin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glycated Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glycated Albumin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glycated Albumin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glycated Albumin Sales by Type (2021-2032)
- 6.1.1 Global Glycated Albumin Sales by Type (2021-2032) & (Kits)
- 6.1.2 Global Glycated Albumin Sales Market Share by Type (2021-2032)
- 6.2 Global Glycated Albumin Revenue by Type (2021-2032)
- 6.2.1 Global Glycated Albumin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glycated Albumin Revenue Market Share by Type (2021-2032)
- 6.3 Global Glycated Albumin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glycated Albumin Sales by Application (2021-2032)
- 7.1.1 Global Glycated Albumin Sales by Application (2021-2032) & (Kits)
- 7.1.2 Global Glycated Albumin Sales Market Share by Application (2021-2032)
- 7.2 Global Glycated Albumin Revenue by Application (2021-2032)
- 7.2.1 Global Glycated Albumin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glycated Albumin Revenue Market Share by Application (2021-2032)
- 7.3 Global Glycated Albumin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glycated Albumin Value Chain Analysis
- 8.1.1 Glycated Albumin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glycated Albumin Production Mode & Process
- 8.2 Glycated Albumin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glycated Albumin Distributors
- 8.2.3 Glycated Albumin Customers
9 Global Glycated Albumin Analyzing Market Dynamics
- 9.1 Glycated Albumin Industry Trends
- 9.2 Glycated Albumin Industry Drivers
- 9.3 Glycated Albumin Industry Opportunities and Challenges
- 9.4 Glycated Albumin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst